Chargement en cours...
Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer
BACKGROUND: A synergistic effect of cyclooxygenase inhibitors (COX‐I) and immune checkpoint inhibitors (ICIs) has been suggested. However, the impact of COX‐I on the efficacy of ICIs is unclear. Here, we aimed to evaluate the relationship between COX‐I use and the efficacy of ICI in patients with no...
Enregistré dans:
| Publié dans: | Thorac Cancer |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons Australia, Ltd
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7952791/ https://ncbi.nlm.nih.gov/pubmed/33559253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13845 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|